Wall $t Banker$$

[micasey123]

I'm in MZT .

Matritech's NMP22(R) BladderChek(R) Test Detected Cancers Not Found By Current Methods
Thursday April 6, 9:40 am ET
The NMP22 BladderChek Point-of-care Assay Identified Tumors Outside Viewing Area of the Cystoscope
Results Presented at Largest Urology Conference in Europe


NEWTON, Mass.--(BUSINESS WIRE)--April 6, 2006--The clinical performance of Matritech's (Amex: MZT - News) NMP22® BladderChek® Test, a point-of-care urine test, in detecting occult bladder cancers was presented today at the 21st Annual Congress of the European Association of Urology (EAU) in Paris. The NMP22 BladderChek Test was reported to detect all of the cancers that occurred in the upper urinary tract of patients with risk factors or symptoms of bladder cancer. Cystoscopy (a visual examination of the interior of the bladder using a scope inserted through the urethra) did not identify these tumors because they were outside the viewing area of the instrument. The tumors were also not detected by cytology, a commonly used laboratory test.